miR-30a-5p promotes glomerular podocyte apoptosis via DNMT1-mediated hypermethylation under hyperhomocysteinemia

Abnormal elevation of homocysteine (Hcy) level is closely related to the development and progression of chronic kidney disease (CKD), with the molecular mech2anisms that are not fully elucidated. Given the demonstration that miR-30a-5p is specifically expressed in glomerular podocytes, in the present study we aimed to investigate the role and potential underlying mechanism of miR-30a-5p in glomerular podocyte apoptosis induced by Hcy. We found that elevated Hcy downregulates miR-30a-5p expression in the Cbs +/-- mice and Hcy-treated podocytes, and miR-30a-5p directly targets the 3′-untranslated region (3′-UTR) of the forkhead box A1 (FOXA1) and overexpression of miR-30a-5p inhibits FOXA1 expression. By nMS-PCR and MassARRAY quantitative methylation analysis, we showed the increased DNA methylation level of miR-30a-5p promoter both in vivo and in vitro. Meanwhile, dual-luciferase reporter assay showed that the region between --1400 and --921 bp of miR-30a-5p promoter is a possible regulatory element for its transcription. Mechanistic studies indicated that DNA methyltransferase enzyme 1 (DNMT1) is the key regulator of miR-30a-5p, which in turn enhances miR-30a-5p promoter methylation level and thereby inhibits its expression. Taken together, our results revealed that epigenetic modification of miR-30a-5p is involved in glomerular podocyte injury induced by Hcy, providing a diagnostic marker candidate and novel therapeutic target in CKD induced by Hcy.

[1]  Robert J. Schmitz,et al.  DNA Methylation: Shared and Divergent Features across Eukaryotes. , 2019, Trends in genetics : TIG.

[2]  D. Bourc’his,et al.  The diverse roles of DNA methylation in mammalian development and disease , 2019, Nature Reviews Molecular Cell Biology.

[3]  Pin-Lan Li,et al.  Rac1 GTPase Inhibition Blocked Podocyte Injury and Glomerular Sclerosis during Hyperhomocysteinemia via Suppression of Nucleotide-Binding Oligomerization Domain-Like Receptor Containing Pyrin Domain 3 Inflammasome Activation , 2019, Kidney and Blood Pressure Research.

[4]  Gang Yin,et al.  Methylation-mediated repression of MiR-424/503 cluster promotes proliferation and migration of ovarian cancer cells through targeting the hub gene KIF23 , 2019, Cell cycle.

[5]  G. Wei,et al.  Aberrant MFN2 transcription facilitates homocysteine‐induced VSMCs proliferation via the increased binding of c‐Myc to DNMT1 in atherosclerosis , 2019, Journal of cellular and molecular medicine.

[6]  T. Benzing,et al.  Glomerular podocytes in kidney health and disease , 2019, The Lancet.

[7]  N. Vanacore,et al.  MicroRNAs and mild cognitive impairment: A systematic review , 2019, Ageing Research Reviews.

[8]  M.D. Wang,et al.  MicroRNA-770-5p is involved in the development of diabetic nephropathy through regulating podocyte apoptosis by targeting TP53 regulated inhibitor of apoptosis 1. , 2019, European review for medical and pharmacological sciences.

[9]  H. Jakubowski.  Homocysteine Modification in Protein Structure/Function and Human Disease. , 2019, Physiological reviews.

[10]  Han-yang Ye,et al.  Down‐regulation of the long non‐coding RNA XIST ameliorates podocyte apoptosis in membranous nephropathy via the miR‐217–TLR4 pathway , 2018, Experimental physiology.

[11]  S. Jacobsen,et al.  A DNA methylation reader complex that enhances gene transcription , 2018, Science.

[12]  Z. Liang,et al.  MicroRNA-29a enhances autophagy in podocytes as a protective mechanism against high glucose-induced apoptosis by targeting heme oxygenase-1. , 2018, European Review for Medical and Pharmacological Sciences.

[13]  Shou-zhi Fu,et al.  MiR-590-3p Attenuates Acute Kidney Injury by Inhibiting Tumor Necrosis Factor Receptor-Associated Factor 6 in Septic Mice , 2018, Inflammation.

[14]  Shou-zhi Fu,et al.  MiR-590-3p Attenuates Acute Kidney Injury by Inhibiting Tumor Necrosis Factor Receptor-Associated Factor 6 in Septic Mice , 2018, Inflammation.

[15]  K. Satyamoorthy,et al.  Clustered miRNAs and their role in biological functions and diseases , 2018, Biological reviews of the Cambridge Philosophical Society.

[16]  W. Yuan,et al.  Effect of exosomal miRNA on cancer biology and clinical applications , 2018, Molecular Cancer.

[17]  Dong-Mei Wu,et al.  Repression of microRNA‐382 inhibits glomerular mesangial cell proliferation and extracellular matrix accumulation via FoxO1 in mice with diabetic nephropathy , 2018, Cell proliferation.

[18]  Trey Ideker,et al.  DNA Methylation Clocks in Aging: Categories, Causes, and Consequences. , 2018, Molecular cell.

[19]  M. Guo,et al.  miR-30 Family: A Promising Regulator in Development and Disease , 2018, BioMed research international.

[20]  F. Lyko.  The DNA methyltransferase family: a versatile toolkit for epigenetic regulation , 2017, Nature Reviews Genetics.

[21]  M. Zhang,et al.  Homocysteine inhibits endothelial progenitor cells proliferation via DNMT1‐mediated hypomethylation of Cyclin A , 2018, Experimental cell research.

[22]  Y. Jiao,et al.  Homocysteine activates autophagy by inhibition of CFTR expression via interaction between DNA methylation and H3K27me3 in mouse liver , 2018, Cell Death & Disease.

[23]  Yuan Gao,et al.  Reciprocal Regulation Between miR-148a/152 and DNA Methyltransferase 1 Is Associated with Hyperhomocysteinemia-Accelerated Atherosclerosis. , 2017, DNA and cell biology.

[24]  K. Boini,et al.  Contribution of guanine nucleotide exchange factor Vav2 to NLRP3 inflammasome activation in mouse podocytes during hyperhomocysteinemia , 2017, Free radical biology & medicine.

[25]  M. Esteller,et al.  MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors , 2017, Molecular Cancer.

[26]  S. Merali,et al.  Homocysteine modulates 5‐lipoxygenase expression level via DNA methylation , 2016, Aging cell.

[27]  Xiangying Zhang,et al.  Regulation of podocyte lesions in diabetic nephropathy via miR-34a in the Notch signaling pathway , 2016, Medicine.

[28]  E. Carney.  Podocyte biology: Dynamic control of actin remodelling , 2016, Nature Reviews Nephrology.

[29]  Yideng Jiang,et al.  miR-125b targets DNMT3b and mediates p53 DNA methylation involving in the vascular smooth muscle cells proliferation induced by homocysteine. , 2016, Experimental cell research.

[30]  Yan Bao,et al.  Overexpression of miR-34c inhibits high glucose-induced apoptosis in podocytes by targeting Notch signaling pathways. , 2015, International journal of clinical and experimental pathology.

[31]  S. Tabibzadeh,et al.  Homocysteine in Chronic Kidney Disease. , 2015, Advances in clinical chemistry.

[32]  K. Zen,et al.  Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids. , 2014, Journal of the American Society of Nephrology : JASN.

[33]  C. Englert,et al.  Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1 , 2013, Nature Medicine.

[34]  X. Yao,et al.  MicroRNA-195 Promotes Apoptosis in Mouse Podocytes via Enhanced Caspase Activity Driven by BCL2 Insufficiency , 2011, American Journal of Nephrology.